Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;31(4):446-51.
doi: 10.1007/s12291-016-0553-1. Epub 2016 Jan 29.

Association of Elevated Serum Lipoprotein(a), Inflammation, Oxidative Stress and Chronic Kidney Disease with Hypertension in Non-diabetes Hypertensive Patients

Affiliations

Association of Elevated Serum Lipoprotein(a), Inflammation, Oxidative Stress and Chronic Kidney Disease with Hypertension in Non-diabetes Hypertensive Patients

Surapon Tangvarasittichai et al. Indian J Clin Biochem. 2016 Oct.

Abstract

Hypertension is the most common cardiovascular risk factor. Lipoprotein(a) [Lp(a)], inflammation, oxidative stress and chronic kidney disease (CKD) exacerbate the response to tissue injury and acts as markers of the vascular disease, especially in glomerulosclerosis. We compared the clinical characteristics of 138 non-diabetes hypertensive women (ndHT) patients with 417 non-diabetes normotensive subjects and tested the association of hypertension with Lp(a), inflammation, CKD and oxidative stress by using multiple logistic regression. BP, BMI, waist circumference, creatinine, Lp(a), inflammation and malondialdehyde levels were significantly higher and CKD state in the ndHT patients (p < 0.05). Multiple logistic regression showed hypertension associated with increased Lp(a), inflammation, ORs and 95 % CIs were 2.52 (1.33, 4.80), 2.75 (1.44, 5.27) after adjusting for their covariates. Elevated serum Lp(a) and inflammation levels concomitants with increased oxidative stress and CKD were the major risk factors associated with hypertension and implications for the increased risk of HT and vascular disease.

Keywords: Chronic kidney disease; Hypertension; Lipoprotein(a); Malondialdehyde; hs-CRP.

PubMed Disclaimer

References

    1. Catena C, Novello M, Lapenna R, Baroselli S, Colussi G, Nadalini E, et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) J Hypertens. 2005;23:1617–1631. doi: 10.1097/01.hjh.0000178835.33976.e7. - DOI - PubMed
    1. Sechi LA, Catena C, Casaccio D, Zingaro L. Lipoprotein(a), haemostatic variables, and cardiovascular damage in hypertensive patients. J Hypertens. 2000;18:709–716. doi: 10.1097/00004872-200018060-00008. - DOI - PubMed
    1. Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. Kidney Int. 1999;56:1049–1057. doi: 10.1046/j.1523-1755.1999.00621.x. - DOI - PubMed
    1. Scanu AM. Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications. Curr Atheroscler Rep. 2003;5:106–113. doi: 10.1007/s11883-003-0081-3. - DOI - PubMed
    1. Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) Circulation. 1995;91:948–950. doi: 10.1161/01.CIR.91.4.948. - DOI - PubMed

LinkOut - more resources